Search

Now showing items 1-10 of 25

The prevalence of tardive dyskinesia after a nine month naturalistic randomized trial comparing olanzapine with conventional treatment for schizophrenia and related disorders

Mari, Jair de Jesus; Lima, Mauricio Silva de; Costa, Anna Maria Niccolai; Alexandrino, Neusa; Rodrigues Filho, Salomao; Oliveira, Irismar Reis de; Tollefson, Gary D. (Springer Verlag, 2004)

Does the degree of smoking effect the severity of tardive dyskinesia? A longitudinal clinical trial

DIEHL, A.; REINHARD, I.; SCHMITT, A.; MANN, K.; GATTAZ, W. F. (ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER, 2009)

Background. - Tardive dyskinesia (TD) is a movement disorder observed after chronic neuroleptic treatment. Smoking is presumed to increase the prevalence of TD. The question of a cause-effect-relationship between smoking ...

EFEITOS DA SUPLEMENTAÇÃO COM ÁCIDOS GRAXOS OMEGA 3 NOS DISTÚRBIOS MOTORES E DISFUNÇÃO COGNITIVA DE PACIENTES TRATADOS COM ANTIPSICÓTICOS TÍPICOS

Cardoso, Patricia Medianeira Ferreira (Universidade Federal de Santa MariaBRFarmacologiaUFSMPrograma de Pós-Graduação em Farmacologia, 2009-06-29)

About 20 to 25 % of psychiatric patients treated with typical antipsychotics may develop an important movement disorder named tardive dyskinesia, with complex etiology and no effective treatment. Cognitive loss is also ...

A study on the action of two calcium channel blockers (verapamil and flunarizine) upon an experimental model of tardive dyskinesia in rats

Pereira, João S.; Bertolucci, Paulo Henrique Ferreira; Ferraz, Henrique B.; Andrade, Luiz A. F. De (Academia Brasileira de Neurologia - ABNEURO, 1992-09-01)

Tardive dyskinesia (TD), a serious complications of neuroleptic chronic use, has no effective therapy yet. We performed an experiment to study the action on TD, of the calcium channel blockers (CCB) drugs, verapamil and ...

The Dystonia - Tardive Dyskinesia Syndrome: Case Report And Discussion Of Clinical, Neurofunctional And Therapeutic Features [a Sindrome Distonia - Discinesia Tardia: Relato De Caso E Discussao De Aspectos Clinicos, Neurofuncionais E Terapeuticos]

Soares F.N.; Nucci M.G.; Dalgalarrondo P. (, 1997)

Incidence Of Tardive Dyskinesia And Its Characteristics In A Mental Health Hospital In Brazil [incidencia Da Discinesia Tardia E Suas Caracteristicas Num Hospital Psiquiatrico Do Nosso Meio]

Moura D.S.P.; Karniol I.G. (, 1980)

A DOUBLE-BLIND-STUDY ON THE EFFECT OF L-DOPA IN PSYCHOTIC-PATIENTS WITH TARDIVE-DYSKINESIA

KARNIOL, IG; GIAMPIETRO, AC; MOURA, DSP; VILELA, WA; OLIVEIRA, MAS; ZUARDI, AW (Fundacion ActaBuenos AiresArgentina, 1983)

OXPRENOLOL IN SCHIZOPHRENIC-PATIENTS WITH TARDIVE-DYSKINESIA - A DOUBLE-BLIND PLACEBO-CONTROLLED, CROSSOVER STUDY

KARNIOL, IG; PORTELA, W (Assoc Bras Divulg CientificaSao PauloBrasil, 1982)

Efeito da dieta hiperlipídica e da tintura de Valeriana officinalis no modelo crônico de discinesia orofacial induzida por haloperidol em ratos

Fachinetto, Roselei (Universidade Federal de Santa MariaBRBioquímicaUFSMPrograma de Pós-Graduação em Ciências Biológicas: Bioquímica Toxicológica, 2006-10-30)

Haloperidol-induced orofacial dyskinesia (OD) is a putative animal model of tardive dyskinesia (TD) whose pathophysiology has been related to an increase in dopamine turnover, reduction in gabaergic neurotransmission and ...

Papel da recaptação e de metabólitos da dopamina na discinesia orofacial induzida por neurolépticos em ratos

Fachinetto, Roselei (Universidade Federal de Santa MariaBRBioquímicaUFSMPrograma de Pós-Graduação em Ciências Biológicas: Bioquímica Toxicológica, 2008-05-12)

Fluphenazine-induced orofacial dyskinesia (OD) is a putative animal model of tardive dyskinesia (TD) whose pathophysiology has been related to an increase in dopamine hypersensitivity and oxidative stress. Data from ...